BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 20807085)

  • 1. Kinetic prerequisites of oximes as effective reactivators of organophosphate-inhibited acetylcholinesterase: a theoretical approach.
    Worek F; Aurbek N; Wille T; Eyer P; Thiermann H
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):303-8. PubMed ID: 20807085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes.
    Worek F; Wille T; Koller M; Thiermann H
    Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of organophosphate-inhibited human acetylcholinesterase by isonitrosoacetone (MINA): a kinetic analysis.
    Worek F; Thiermann H
    Chem Biol Interact; 2011 Nov; 194(2-3):91-6. PubMed ID: 21930118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
    Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
    Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
    Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
    Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of interactions between alkylene-linked bis-pyridiniumaldoximes and human acetylcholinesterases inhibited by various organophosphorus compounds.
    Wille T; Ekström F; Lee JC; Pang YP; Thiermann H; Worek F
    Biochem Pharmacol; 2010 Sep; 80(6):941-6. PubMed ID: 20510679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
    Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
    Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach.
    Worek F; Wille T; Aurbek N; Eyer P; Thiermann H
    Toxicol Appl Pharmacol; 2010 Dec; 249(3):231-7. PubMed ID: 20888357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
    Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of human and guinea pig acetylcholinesterase sequences and rates of oxime-assisted reactivation.
    Cadieux CL; Broomfield CA; Kirkpatrick MG; Kazanski ME; Lenz DE; Cerasoli DM
    Chem Biol Interact; 2010 Sep; 187(1-3):229-33. PubMed ID: 20433814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes.
    Worek F; Thiermann H; Szinicz L; Eyer P
    Biochem Pharmacol; 2004 Dec; 68(11):2237-48. PubMed ID: 15498514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of medical countermeasures against organophosphorus compounds: the value of experimental data and computer simulations.
    Worek F; Aurbek N; Herkert NM; John H; Eddleston M; Eyer P; Thiermann H
    Chem Biol Interact; 2010 Sep; 187(1-3):259-64. PubMed ID: 19917271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism for potent reactivation ability of H oximes analyzed by reactivation kinetic studies with cholinesterases from different species.
    Luo C; Chambers C; Yang Y; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):185-90. PubMed ID: 20096273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
    Horn G; de Koning MC; van Grol M; Thiermann H; Worek F
    Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
    Scheffel C; Thiermann H; Worek F
    Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic interactions of a homologous series of bispyridinium monooximes (HGG oximes) with native and phosphonylated human acetylcholinesterase.
    Worek F; Bierwisch A; Wille T; Koller M; Thiermann H
    Toxicol Lett; 2012 Jul; 212(1):29-32. PubMed ID: 22561105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
    Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
    Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.